Wednesday, December 19, 2012
2013 Europe Healthcare Predictions - Squeezed Supply Chain Offers Business Opportunities
With public and private finances squeezed and austerity measures adopted across all major country markets, healthcare organisations across Europe are facing pressure to increase efficiency in the supply chain. This pressure acts as a catalyst, speeding up the pace of change towards a sustainable healthcare system.
This pressure also presents an opportunity for healthcare managers of all levels to elevate the supply chain from an operational necessity to a strategic asset, creating business opportunities from a challenging position. Here’s our consolidated view of trends we’re likely to see in Europe in 2013:
- Accelerated focus on the supply chain: Whether healthcare in the respective European country markets is predominantly publicly funded, as in the UK and Spain, or privately funded, as in Germany and Switzerland, the focus for all member states to reduce their deficits will increase the importance of the supply chain and the focus on reducing operational inefficiency.
- Requirement for system integration and interoperability: Healthcare organisations have evolved separately and chosen different technology service providers along the way. This creates an imperative for integration between disparate technology platforms. We predict that we the demand for integration expertise to manage this situation and enable end-to-end solutions will increase steadily throughout 2013 as providers and suppliers look to deliver interoperability.
- Increased dependence on supply chain visibility and reporting: A natural next step is to demand better visibility into the supply chain. The supply chain can be viewed as the backbone of a business, which can help them capture and share the data they need to make better business decisions. Across Europe, large parts of the healthcare supply chain remain invisible. Technology can overcome this issue.
An example of this is the efforts of GHX Europe to define an enhanced managed inventory supply chain solution, helping enable improvements in business processes, facilitate track and trace and product identification in the event of recalls.
- Greater global commonality: Some issues are global – standardization and our approach to product identification and traceability is one of these issues. The FDA ruling on UDI in 2012 and the similar proposals published by the European Commission will drive adoption of standards both sides of the Pond. This is just one the areas of commonality in an increasingly global healthcare market. 2013 will continue see this trend continue, bringing greater collaboration across country and regional boarders in Europe and beyond.
If you’d like to read more about the GHX Europe predictions, we put out a press release today that talks about them in more detail. Give it a read and let us know what you think in the comment section. I look forward to hearing from you.